Kamada Ltd. — Regulatory Filings 2014

Jan 29, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

For the Month of January 2014

Commission File Number 001-35948

Kamada Ltd.

(Translation of registrant’s name into English)

7 Sapir St. Kiryat Weizmann Science Park P.O Box 4081 Ness Ziona 74140 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

---

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

---

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  No 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-____

This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statement File No. 333192720.

EXPLANATORY NOTE

Kamada Ltd. announces the results of the Extraordinary General Meeting of Shareholders that was held on January 28, 2014. The following exhibit is attached:

99.1 Notice of Results of the Extraordinary General Meeting of Shareholders.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 28, 2014

KAMADA LTD.

By: /s/ Gil Efron_____ Gil Efron Chief Financial Officer

EXHIBIT 99.1

KAMADA LTD.

7 Sapir Street Kiryat Weizmann Science Park P.O Box 4081 Ness Ziona 74140, Israel

Notice of Results of Extraordinary General Meeting of Shareholders

Kamada Ltd. (the “ Company ”) today announced that all of the proposals submitted for shareholder approval were duly approved at its Extraordinary General Meeting of Shareholders held on January 28, 2014 in Ness Ziona, Israel (the “ Meeting ”). Accordingly, at the Meeting, shareholders of the Company approved the following:

• (i) The adoption of an amended compensation policy with respect to the terms of service and employment of the Company’s office holders, as such term is defined in the Israeli Companies Law, 5759-1999 (the “ Israeli Companies Law ”).

• (ii) The re-election of Dr. Abraham Havron as an outside director (within the meaning of the Israeli Companies Law) for an additional three-year term.

• (iii) The election of Dr. Estery Giloz-Ran as an outside director (within the meaning of the Israeli Companies Law) for an initial three-year term.

• (iv) The authorization of the Company’s entering into an indemnification agreement with Dr. Estery Giloz-Ran.

• (v) The grant of options to the Company’s outside directors, including Dr. Estery Giloz-Ran.

• (vi) The grant of options to each of the Company’s directors, other than its outside directors (within the meaning of the Israeli Companies Law), the chairman of its board of directors and its chief executive officer.

• (vii) The grant of options to Mr. Leon Recanati, the chairman of the board of directors of the Company.

• (viii) The updated compensation terms (including the grant of options) for Mr. David Tsur, the Company’s chief executive officer and a director.

January 28, 2014